Literature DB >> 27418631

RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.

Pasquale Simeone1, Saverio Alberti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27418631      PMCID： PMC5017948          DOI： 10.1093/jnci/djw143

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Long-range transcriptome sequencing reveals cancer cell growth regulatory chimeric mRNA.

Authors:  Roberto Plebani; Gavin R Oliver; Marco Trerotola; Emanuela Guerra; Pamela Cantanelli; Luana Apicella; Andrew Emerson; Alessandro Albiero; Paul D Harkin; Richard D Kennedy; Saverio Alberti
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

2.  A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.

Authors:  Emanuela Guerra; Marco Trerotola; Roberta Dell' Arciprete; Veronica Bonasera; Barbara Palombo; Tarek El-Sewedy; Tommaso Ciccimarra; Carlo Crescenzi; Franco Lorenzini; Cosmo Rossi; Giovanna Vacca; Rossano Lattanzio; Mauro Piantelli; Saverio Alberti
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

3.  Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.

Authors:  Sudheer Kumar Gara; Li Jia; Maria J Merino; Sunita K Agarwal; Lisa Zhang; Maggie Cam; Dhaval Patel; Electron Kebebew
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

4.  Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.

Authors:  Siân Jones; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; Hirohiko Kamiyama; Antonio Jimeno; Seung-Mo Hong; Baojin Fu; Ming-Tseh Lin; Eric S Calhoun; Mihoko Kamiyama; Kimberly Walter; Tatiana Nikolskaya; Yuri Nikolsky; James Hartigan; Douglas R Smith; Manuel Hidalgo; Steven D Leach; Alison P Klein; Elizabeth M Jaffee; Michael Goggins; Anirban Maitra; Christine Iacobuzio-Donahue; James R Eshleman; Scott E Kern; Ralph H Hruban; Rachel Karchin; Nickolas Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

5.  HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.

Authors:  Tao Zhang; Mingzhao Xing
Journal:  J Natl Cancer Inst       Date:  2016-02-01       Impact factor: 13.506

6.  deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data.

Authors:  Andrew McPherson; Fereydoun Hormozdiari; Abdalnasser Zayed; Ryan Giuliany; Gavin Ha; Mark G F Sun; Malachi Griffith; Alireza Heravi Moussavi; Janine Senz; Nataliya Melnyk; Marina Pacheco; Marco A Marra; Martin Hirst; Torsten O Nielsen; S Cenk Sahinalp; David Huntsman; Sohrab P Shah
Journal:  PLoS Comput Biol       Date:  2011-05-19       Impact factor: 4.475

7.  HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.

Authors:  Tamara Mirzapoiazova; Nurbek Mambetsariev; Frances E Lennon; Bolot Mambetsariev; Joshua E Berlind; Ravi Salgia; Patrick A Singleton
Journal:  Front Oncol       Date:  2015-07-21       Impact factor: 6.244
  7 in total
  3 in total

Review 1.  Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.

Authors:  José Manuel Cameselle-Teijeiro; Ozgur Mete; Sylvia L Asa; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2021-01-25       Impact factor: 3.943

Review 2.  Pharmacogenetic and pharmacogenomic discovery strategies.

Authors:  Concetta Crisafulli; Petronilla Daniela Romeo; Marco Calabrò; Ludovica Martina Epasto; Saverio Alberti
Journal:  Cancer Drug Resist       Date:  2019-06-19

3.  Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer.

Authors:  Glenn S Gerhard; Darrin V Bann; James Broach; David Goldenberg
Journal:  NPJ Genom Med       Date:  2017-03-28       Impact factor: 8.617
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.